rs427483
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000022.4(ADA):c.33+382G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.258 in 152,156 control chromosomes in the GnomAD database, including 5,396 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.26 ( 5396 hom., cov: 33)
Consequence
ADA
NM_000022.4 intron
NM_000022.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.306
Publications
7 publications found
Genes affected
ADA (HGNC:186): (adenosine deaminase) This gene encodes an enzyme that catalyzes the hydrolysis of adenosine to inosine in the purine catabolic pathway. Various mutations have been described for this gene and have been linked to human diseases related to impaired immune function such as severe combined immunodeficiency disease (SCID) which is the result of a deficiency in the ADA enzyme. In ADA-deficient individuals there is a marked depletion of T, B, and NK lymphocytes, and consequently, a lack of both humoral and cellular immunity. Conversely, elevated levels of this enzyme are associated with congenital hemolytic anemia. [provided by RefSeq, Sep 2019]
ADA Gene-Disease associations (from GenCC):
- severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Myriad Women’s Health, Orphanet
- Omenn syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.333 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ADA | NM_000022.4 | c.33+382G>C | intron_variant | Intron 1 of 11 | ENST00000372874.9 | NP_000013.2 | ||
| ADA | NM_001322051.2 | c.33+382G>C | intron_variant | Intron 1 of 10 | NP_001308980.1 | |||
| ADA | NM_001322050.2 | c.-257+382G>C | intron_variant | Intron 1 of 10 | NP_001308979.1 | |||
| ADA | NR_136160.2 | n.125+382G>C | intron_variant | Intron 1 of 10 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ADA | ENST00000372874.9 | c.33+382G>C | intron_variant | Intron 1 of 11 | 1 | NM_000022.4 | ENSP00000361965.4 | |||
| ADA | ENST00000695995.1 | c.33+382G>C | intron_variant | Intron 1 of 8 | ENSP00000512318.1 | |||||
| ADA | ENST00000695991.1 | c.33+382G>C | intron_variant | Intron 1 of 7 | ENSP00000512314.1 | |||||
| ADA | ENST00000696038.1 | n.33+382G>C | intron_variant | Intron 1 of 8 | ENSP00000512344.1 |
Frequencies
GnomAD3 genomes AF: 0.258 AC: 39176AN: 152038Hom.: 5394 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
39176
AN:
152038
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.258 AC: 39194AN: 152156Hom.: 5396 Cov.: 33 AF XY: 0.255 AC XY: 18946AN XY: 74386 show subpopulations
GnomAD4 genome
AF:
AC:
39194
AN:
152156
Hom.:
Cov.:
33
AF XY:
AC XY:
18946
AN XY:
74386
show subpopulations
African (AFR)
AF:
AC:
7442
AN:
41536
American (AMR)
AF:
AC:
5198
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
517
AN:
3470
East Asian (EAS)
AF:
AC:
1335
AN:
5152
South Asian (SAS)
AF:
AC:
981
AN:
4828
European-Finnish (FIN)
AF:
AC:
2623
AN:
10596
Middle Eastern (MID)
AF:
AC:
48
AN:
294
European-Non Finnish (NFE)
AF:
AC:
20238
AN:
67982
Other (OTH)
AF:
AC:
549
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1483
2965
4448
5930
7413
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
398
796
1194
1592
1990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
831
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.